Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma
TH Open · 15.09.2026 · 10 (CP)
DOI: 10.1055/a-2925-6824 ↗Kurz gefasst
Fachartikel in der Zeitschrift TH Open, erschienen am 15.09.2026. Verfasst von Ruth A L Willems und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional CoagulationSynapse Research InstituteMaastrichtLimburgThe Netherlands. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Thromboembolic complications are common in patients with pancreatic cancer, with up to 20% of patients developing venous thromboembolism. While hypercoagulation in pancreatic cancer has been widely studied, fibrinolysis is less well characterized. Plasmin generation (PG) is a novel approach to assess fibrinolytic activity and may provide new insights into thrombotic risk in this population. This study aimed to compare the PG profile of patients with pancreatic cancer with that of healthy individuals.
Methods
This single-center cohort study included patients with advanced pancreatic cancer initiating chemotherapy at the Maastricht University Medical Center between 2022 and 2023. Plasma samples were obtained before chemotherapy (t 0) and 8 weeks later (t 8). PG and thrombin generation (TG) were measured; TG/PG ratios were calculated to evaluate the balance between coagulation and fibrinolysis. Thromboembolic events were recorded for 6 months.
Results
In total, 18 patients with pancreatic cancer and 18 healthy subjects were included. At baseline, patients showed higher endogenous plasmin potential levels compared with controls, whereas PG remained elevated at t 8 despite chemotherapy. PG lag time was prolonged in patients at t 8. Patients showed lower TG/PG ratios for endogenous thrombin/plasmin potential. Five patients (28%) developed thromboembolic events. Although PG parameters were not associated with thromboembolic events, patients who developed thromboembolic events showed lower TG/PG potential ratios.
Conclusion
Patients with pancreatic cancer exhibited a disbalance in their PG profile, with a delayed but increased capacity to generate plasmin. Future studies are required to assess whether PG associates with thromboembolic disease and survival.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Functional CoagulationSynapse Research InstituteMaastrichtLimburgThe Netherlands.
- Division of Medical Oncology and Vascular MedicineDepartment of Internal MedicineMaastricht University Medical CenterMaastrichtLimburgThe Netherlands.
- Thrombosis Expert Center Maastricht, Maastricht University Medical CenterMaastrichtLimburgThe Netherlands.
- CARIM, School for Cardiovascular Diseases, Maastricht UniversityMaastrichtLimburgThe Netherlands.
- Department of Platelet PathophysiologySynapse Research InstituteMaastrichtLimburgThe Netherlands.
- Division of Medical OncologyDepartment of Internal MedicineMaastricht University Medical CenterMaastrichtLimburgThe Netherlands.
ORCID-Profile: Ruth A L Willems, Hugo Ten Cate, Dana Huskens
Zitieren
APA
Willems, R. A. L., De Simone, I., Tufaha, S., Konings, J., Middelveld, H., Pepels-Aarts, N., Cate, H. T., De Laat, B., Roest, M., Huskens, D., & de Vos-Geelen, J. (2026). Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma. TH Open, 10(CP). https://doi.org/10.1055/a-2925-6824
Vancouver
Willems RAL, De Simone I, Tufaha S, Konings J, Middelveld H, Pepels-Aarts N, et al. Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma. TH Open. 2026;10(CP). doi:10.1055/a-2925-6824
BibTeX
@article{Willems2026,
author = {Willems, Ruth A L and De Simone, Ilaria and Tufaha, Samia and Konings, Joke and Middelveld, Harmen and Pepels-Aarts, Nicol and Cate, Hugo Ten and De Laat, Bas and Roest, Mark and Huskens, Dana and de Vos-Geelen, Judith},
title = {Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma},
journal = {TH Open},
year = {2026},
volume = {10},
number = {CP},
doi = {10.1055/a-2925-6824}
}
EUVIMED